NCT06955624View on ClinicalTrials.gov

Use of Omics Methods to Classify Variations of Uncertain Significance and Improve Diagnosis of Neurogenetic Diseases

NARecruitingINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

January 15, 2030

Study Completion Date

January 15, 2031

Conditions
Neurogenetic Diseases
Interventions
GENETIC

RNA and/or DNA methylation and/or protein analysis

RNA and/or DNA methylation and/or protein analysis from a blood sample or another tissue including dedifferenciation into induced pluripotent stem cells

Trial Locations (1)

Unknown

RECRUITING

Rouen University Hospital, Rouen

All Listed Sponsors
collaborator

University Hospital, Lille

OTHER

collaborator

Groupe Hospitalier Pitie-Salpetriere

OTHER

lead

University Hospital, Rouen

OTHER